|
|||||
|
|
Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital |
|
| Authors: | Changela Ursula Cannon Joan P Aneziokoro Chinyere Shah Palak S Thottapurathu Lizy Lentino Joseph |
| Affiliation: | aPharmacy Services, Edward Hines Jr. VA Hospital, Fifth Avenue and Roosevelt Road, Building 200, Room 1243, Hines, IL 60141, USA bDivision of Infectious Diseases, Loyola University of Chicago Medical Center, Maywood, IL, USA cSection of Infectious Diseases/Medical Service, Edward Hines Jr. VA Hospital, Hines, IL, USA dDepartment of Pharmacy, Mayo Clinic-St. Luke's Hospital, Jacksonville, FL, USA eCooperative Studies Program Coordinating Center, Edward Hines Jr. VA Hospital, Hines, IL, USA |
| Abstract: | The objective of this study was to evaluate the risk of certain patient co-morbidities and antibiotics in the development of Clostridium difficile-associated diarrhoea (CDAD). Hospitalized patients developing CDAD during a specified period were compared with a cohort of patients, matched by age, without a diagnosis of CDAD, who were hospitalized during the same time period. Data collection included demographics, hospital ward, co-morbid conditions, antibiotics received, and mortality. Gender and age were similar in both groups. Co-morbid conditions significantly associated with the case group included cancer and COPD. The most commonly prescribed antibiotics in the case versus control group included levofloxacin, intravenous vancomycin, clindamycin, and piperacillin/tazobactam. The case group was associated with a higher mortality rate. |
| Keywords: | Clostridium difficile Antibiotics Mortality Risk factors |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |